Skip to content
Clinical Trials – home

Medical Center Medicabilis Ltd.

Verifiedinfo

Bulgaria Ulitsa Kliment Ohridski 3a, 1756 Sofia, Bulgaria

  • 6 trials recruiting
  • Hypertension · Chronic kidney disease · Cardiovascular disorder
  • Adult patients

About Specializations

Medical Center Medicabilis Ltd. in Sofia, Bulgaria specialises in clinical trials of conditions such as Hypertension, Chronic kidney disease, Cardiovascular disorder, Cardiac failure, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for lipid disorders. The center's work in this field is pivotal in understanding and managing conditions that affect heart health.

  • Hyperlipidemia
  • Triglyceride Management
  • Cardiovascular Risk Reduction

By exploring new therapeutic approaches, the center contributes significantly to reducing the burden of cardiovascular diseases globally.

Endocrinology and Metabolism

Specializing in endocrinology and metabolism, the center conducts cutting-edge research on metabolic disorders, particularly focusing on severe hypertriglyceridemia. This research is crucial for developing effective interventions for metabolic health.

  • Severe Hypertriglyceridemia
  • Metabolic Syndrome
  • Insulin Resistance

The center's efforts in this area aim to improve patient outcomes through personalized medicine and advanced therapeutic strategies.

Clinical Pharmacology

The institution excels in clinical pharmacology, focusing on the development and evaluation of novel pharmacological agents. This expertise is instrumental in advancing drug therapies that target specific medical conditions.

  • Drug Development
  • Pharmacokinetics
  • Therapeutic Innovation

Through rigorous clinical trials and research, the center enhances the understanding of drug efficacy and safety, contributing to the broader field of medicine.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Kliment Ohridski 3a1756 SofiaBulgaria
Recruiting now
6 trials
Conditions studied
8
Partner status
Verified

More sites in SofiaBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

11 clinical trials

Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Cardiac failure

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Arteriosclerosis

Not yet recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.